Cargando…
Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea
The Korean clinical practice guideline recently developed by the Korean Breast Cancer Society to address the national clinical situation is currently under revision ahead of a seventh recommendation. A second consensus conference was held to further develop this guideline by soliciting opinions rega...
Autores principales: | Lee, Seeyoun, Park, In Hae, Park, Seho, Sohn, Joohyuk, Jeong, Joon, Ahn, Sung Gwe, Lee, Ik Jae, Lee, Hae Kyung, Lee, Seung Ah, Park, Won, Lee, Kyung-Hun, Kim, Sung-Won, Han, Sang-Ah, Jung, Kyung Hae, Son, Byung Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620436/ https://www.ncbi.nlm.nih.gov/pubmed/28970847 http://dx.doi.org/10.4048/jbc.2017.20.3.228 |
Ejemplares similares
-
Meeting Highlights: The First Korean Breast Cancer Treatment Consensus Conference
por: Han, Airi, et al.
Publicado: (2014) -
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
por: Sim, Sung Hoon, et al.
Publicado: (2019) -
Increase of Prevalence of Obesity and Metabolic Syndrome in Children and Adolescents in Korea during the COVID-19 Pandemic: A Cross-Sectional Study Using the KNHANES
por: Choi, Jung Eun, et al.
Publicado: (2023) -
Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication
por: Kim, Min Hwan, et al.
Publicado: (2015) -
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
por: Park, In Hae, et al.
Publicado: (2019)